Compare SLNO & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLNO | NXE |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 5.9B |
| IPO Year | 2014 | N/A |
| Metric | SLNO | NXE |
|---|---|---|
| Price | $51.42 | $9.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $110.90 | N/A |
| AVG Volume (30 Days) | 1.8M | ★ 7.3M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $98,675,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $155.86 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $41.50 | $3.91 |
| 52 Week High | $90.32 | $9.99 |
| Indicator | SLNO | NXE |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 58.65 |
| Support Level | $47.80 | $8.86 |
| Resistance Level | $53.10 | $9.99 |
| Average True Range (ATR) | 2.47 | 0.48 |
| MACD | 1.09 | 0.18 |
| Stochastic Oscillator | 79.48 | 78.01 |
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
NexGen Energy Ltd is an exploration and development entity engaged in acquiring, evaluating, and developing uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin.